MORC2 and breast carcinoma: In addition, we identified a gain-of-function mutation of MORC2 that was associated with cancer metastasis and that revealed a post-translational modification of MORC2, namely GlcNAcylation at threonine 556, which enhances breast cancer cell migration and invasion [150,151,152].